Complement 5a stimulates hepatic stellate cells in vitro, and is increased in the plasma of patients with chronic hepatitis B

Immunology

Volumn 138, Issue 3, 2013, Pages 228-234

  Xu, Ruonan ^a   Lin, Fang ^a   He, Jin ^a   Jin, Lei ^a   Zhang, Ji Yuan ^a   Fu, Junliang ^a   Liu, Honghong ^a   Wang, Siyu ^a   Zhang, Zheng ^a   Wang, Fu Sheng ^a  

^a BEIJING 302 HOSPITAL   (China)

Author keywords

Complement 5a; Hepatic stellate cell; Hepatitis B virus; Liver fibrosis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; GELATINASE A; HYALURONIC ACID; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADULT; APOPTOSIS; ARTICLE; BLOOD LEVEL; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEPATITIS B; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STELLATE CELL; UPREGULATION;

ADOLESCENT; ADULT; APOPTOSIS; COMPLEMENT C5A; FEMALE; HEPATIC STELLATE CELLS; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RECEPTORS, COMPLEMENT; YOUNG ADULT;

EID: 84873324642     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12024     Document Type: Article

References (19)

1. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5:215-29.
2. Schuppan D, Ruehl M, Somasundaram R, Hahn EG. Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis 2001; 21:351-72.
3. Blomhoff R, Berg T. Isolation and cultivation of rat liver stellate cells. Methods Enzymol 1990; 190:58-71.
4. Elsharkawy AM, Oakley F, Mann DA. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 2005; 10:927-39.
5. Chamber RC, Lurent GJ. Coagulation cascade proteases and tissue fibrosis. Biochem Soc Trans 2002; 30:194-200.
6. Mahmood S, Sho M, Yasuhara Y et al. Clinical significance of intrahepatic interleukin-8 in chronic hepatitis C patients. Hepatol Res 2002; 24:413-9.
7. Mastellos D, Papadimitriou JC, Franchini S, Tsonis PA, Lambris JD. A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration. J Immunol 2001; 166:2479-86.
8. Hillebrandt S, Wasmuth HE, Weiskirchen R et al. Complement factor 5 is a quantitative trait gene that modifies liver. Nat Genet 2005; 37:835-43.
9. Rittirsch D, Flierl MA, Nadeau BA et al. Functional roles for C5a receptors in sepsis. Nat Med 2008; 14:551-7.
10. Schlaf G, Schmitz M, Heine I, Demberg T, Schieferdecker HL, Götze O. Upregulation of fibronectin but not of entactin, collagen IV and smooth muscle actin by anaphylatoxin C5a in rat hepatic stellate cells. Histol Histopathol 2004; 19:1165-74.
11. Zhang Z, Zhang S, Zou Z et al. Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients. Hepatology 2011; 53:73-85.
12. Gressner AM, WeiskirchenR. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets. J Cell Mol Med 2006; 10:76-99.
13. Alison MR, Vig P, Russo F, Bigger BW, Amofah E, Themis M, Forbes S. Hepatic stem cells: from inside and outside the liver? Cell Prolif 2004; 37:1-21.
14. Guo RF, Riedemann NC, Laudes IJ, Sarma VJ, Kunkel RG, Dilley KA, Paulauskis JD, Ward PA. Altered neutrophil trafficking during sepsis. J Immunol 2002; 169:307-14.
15. Haviland DL, McCoy RL, Whitehead WT et al. Cellular expression of the C5a anaphyla- toxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J Immunol 1995; 154:1861-9.
16. Schieferdecker HL, Schlaf G, Jungermann K, Götze O. Functions of anaphylatoxin C5a in rat liver: direct and indirect actions on nonparenchymal and parenchymal cells. Int Immunopharmacol 2001; 1:469-81.
17. Laudes IJ, Chu JC, Huber-Lang M et al. Expression and function of C5a receptor in mouse microvascular endothelial cells. J Immunol 2002; 169:5962-70.
18. Riedemann NC, Guo RF, Laudes IJ, Keller K, Sarma VJ, Padgaonkar V, Zetoune FS, Ward PA. C5a receptor and thymocyte apoptosis in sepsis. FASEB J 2002; 16:887-8.
19. Perianayagam MC, Balakrishnan VS, King AJ, Pereira BJ, Jaber BL. C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway. Kidney Int 2002; 61:456-63.